Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials

Clowse Megan E. B., Wallace Daniel J., Furie Richard A., Petri Michelle A., Pike Marilyn C., Szűcs Gabriella, EMBODY Investigator Group, Kemény Lajos, et al.: Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.
ARTHRITIS & RHEUMATOLOGY, 69 (2). pp. 362-375. ISSN 2326-5191 (2017)

[img] Text
3217512_Clowse.pdf - Published Version
Korlátozott. Repository staff only

Download (360kB) | Request a copy
Item Type: Article
Journal or Publication Title: ARTHRITIS & RHEUMATOLOGY
Date: 2017
Volume: 69
Number: 2
Page Range: pp. 362-375
ISSN: 2326-5191
Publisher: John Wiley and Sons, Inc.
Faculty: Faculty of Medicine
Institution: Szegedi Tudományegyetem
SWORD language: Angol
Identification Number: 3217512
DOI id: https://doi.org/10.1002/art.39856
Date Deposited: 2018. Jan. 17. 10:06
Last Modified: 2018. Jan. 17. 11:20
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12731

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year